Our results show that in vitro stimulation with anti-CD3/CD28 leads to an increase in ALL+ cells within the CD4+ and CD8+ subsets along with an increased expression of gpALL that peaks 48 h post-activation. The gene discussed is CD8A; the disease is acute lymphoblastic leukemia.